Critical Challenges and Guidelines in Evaluating Synthetic Tabular Data: A Systematic Review

TEXT START: Generating synthetic tabular health data is challenging, and evaluating their quality is equally, if not more, complex. This systematic review highlights the critical importance of rigorous evaluation of synthetic health data to ensure reliability, clinical relevance, and appropriate use.

The Dissection

This is a methodology normalization paper dressed in systematic review clothing. It surveys 134 studies on synthetic health data generation and concludes that the field lacks standardization in evaluation metrics. The implicit promise: if we just get our measurement tools right, synthetic data will fulfill its transformative potential.

The paper is not wrong about the technical problem. It is catastrophically limited in diagnosing why that problem persists and what it portends.

The Core Fallacy

The paper assumes synthetic data evaluation is a convergence problem—a matter of finding better taxonomies, consensus metrics, and standardized protocols. It treats the fragmentation of evaluation methods as an implementation deficit rather than a structural signal.

It is structural.

The reason no consensus emerges on how to evaluate synthetic tabular data is that synthetic data in high-stakes domains (health, finance, insurance) is not primarily a technical challenge. It is a legitimacy problem. Every stakeholder—researchers, hospitals, regulators, insurers, patients—has fundamentally different criteria for "good enough," and those criteria are not reconcilable by taxonomy design. The paper wants to build a shared language for evaluating something whose value is inherently contested.

Hidden Assumptions

1. Synthetic health data has a net-positive trajectory. The paper assumes the goal is "responsible development and use" without interrogating whether the use cases being enabled are neutral or extractive.

2. Standardization is desirable. Standardization in synthetic data evaluation will primarily serve institutional adopters (large health systems, pharma) who need compliance cover. It will not serve patients whose data is being used to train these models.

3. "Transparency, reproducibility, and governance" are sufficient. These are procedural commitments, not accountability mechanisms. They make synthetic data pipelines legible to regulators without making them safe for subjects.

4. Domain expert involvement is a fixable bottleneck. The paper identifies "limited involvement of domain experts" as a problem. In reality, domain experts (clinicians, epidemiologists) often lack the technical literacy to audit synthetic pipelines, while the people building those pipelines have no structural incentive to invite scrutiny.

5. The 10-year publication window is evidence of maturation, not noise. 2067 papers identified, 134 reviewed—these numbers are being treated as signs of a healthy field rather than a publication bubble driven by AI hype cycles.

Social Function

Prestige signaling + transition management. The paper performs rigor (systematic review methodology, taxonomies, guidelines) while serving the broader institutional project of normalizing synthetic data generation. It is written for an audience that already believes synthetic data is the future and just needs better tools to make it acceptable.

It is a governance lullaby—it says "here's how we'll know if synthetic data is good," without asking who decides "good," for whom, and at whose expense.

The Verdict

This paper is a procedural band-aid on a structural hemorrhage. It correctly identifies that synthetic data evaluation is fragmented, inconsistent, and insufficient. It incorrectly diagnoses this as a technical methodology problem solvable by standardization.

Under the Discontinuity Thesis, synthetic data generation is not a transitional solution—it is an acceleration mechanism toward the terminal condition. The paper's entire framing assumes synthetic data is a tool to be refined and governed. It does not engage with the possibility that synthetic data at scale is a mechanism for replacing the data subjects (patients, consumers, workers) with cheaper, more controllable digital proxies—proxies whose "quality" is measured entirely by downstream institutional utility, not by the fidelity of representation to the humans from whom the training data was extracted.

The systematic review is methodologically competent. The frame is systemically uncritical. In a field this consequential, that is a failure of the most dangerous kind: competent work on the wrong question.